Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) Assets Average (2018 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Assets Average for 6 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 86.15% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Oct 2025, up 86.15%, and an annual FY2025 reading of $1.7 million, up 187.05% over the prior year.
  • Assets Average was $2.3 million for Q4 2025 at VitaNova Life Sciences, up from $2.2 million in the prior quarter.
  • Across five years, Assets Average topped out at $2.3 million in Q4 2025 and bottomed at $9870.5 in Q2 2023.
  • Average Assets Average over 4 years is $868021.7, with a median of $1.1 million recorded in 2024.
  • The sharpest move saw Assets Average crashed 69.82% in 2023, then soared 10827.58% in 2024.
  • Year by year, Assets Average stood at $32537.0 in 2022, then crashed by 69.66% to $9870.5 in 2023, then soared by 12359.67% to $1.2 million in 2024, then surged by 86.15% to $2.3 million in 2025.
  • Business Quant data shows Assets Average for YJGJ at $2.3 million in Q4 2025, $2.2 million in Q3 2025, and $1.8 million in Q2 2025.